10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||
| ||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBVIE INC. | |||
Ticker: ABBV Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 21, 2014) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
Cash flows from operating activities | |||
Net earnings | $ 4,128 | 5,275 | 3,433 |
Adjustments to reconcile net earnings to net cash from operating activities: | |||
Depreciation | 388 | 525 | 508 |
Amortization of intangible assets | 509 | 625 | 764 |
Stock-based compensation | 212 | 187 | 163 |
Acquired in-process research and development | 338 | 288 | 673 |
Other, net | 34 | 66 | |
Changes in operating assets and liabilities, net of acquisitions: | |||
Accounts and other receivables | 681 | 223 | (498) |
Inventories | (56) | (203) | (87) |
Prepaid expenses and other assets | 459 | 90 | (206) |
Accounts payable and other liabilities | (426) | (731) | 1,497 |
Cash flows from operating activities | 6,267 | 6,345 | 6,247 |
Cash flows from investing activities | |||
Acquisitions and investments, net of cash acquired | (405) | (688) | (273) |
Acquisitions of property and equipment | (491) | (333) | (356) |
Release of restricted funds | 1,870 | ||
Purchases of investment securities | (930) | (2,550) | (1,943) |
Sales and maturities of investment securities | 2,705 | 1,153 | 1,255 |
Cash flows from investing activities | 879 | (2,418) | 553 |
Cash flows from financing activities | |||
Net change in short-term borrowings | (601) | 1,000 | |
Dividends paid | (2,555) | ||
Purchases of treasury stock | (320) | ||
Proceeds from the exercise of stock options | 347 | ||
Proceeds from issuance of long-term debt | 14,586 | ||
Net transactions with Abbott Laboratories, excluding noncash items | (247) | (13,504) | (6,762) |
Other, net | (66) | (151) | (21) |
Cash flows from financing activities | (3,442) | 1,931 | (6,783) |
Effect of exchange rate changes on cash and equivalents | (10) | 16 | |
Net increase in cash and equivalents | 3,694 | 5,874 | 17 |
Cash and equivalents, beginning of year | 5,901 | 27 | |
Cash and equivalents, end of year | 9,595 | 5,901 | 27 |
Other supplemental information | |||
Interest paid, net of portion capitalized | 283 | 61 | |
Income taxes paid | 1,305 |
External Links | |
ABBVIE INC. (ABBV) Fiscal Year 2013 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |